Data / Form D filings / Ensoma, Inc.
Ensoma, Inc.: Form D filings
Ensoma, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on May 23, 2023, reports $129 million sold of a $129 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 451 D Street, Suite 600, Boston, MA, 02210
- Phone
- (617) 272-2400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1846902
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 23, 2023 | Amendment | $129,000,467 | $129,000,467 | 22 | Dec 23, 2022 | sec.gov | |
| Jan 9, 2023 | New notice | $79,000,469 | $79,000,469 | 19 | Dec 23, 2022 | sec.gov | |
| Feb 19, 2021 | New notice | $70,549,902 | $40,549,910 | $29,999,992 | 11 | Feb 5, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paula Soteropoulos | Director | |
| Nihal Sinha | Director | |
| Emile Nuwaysir | Executive Officer, Director | |
| Kush M Parmar | Director | |
| Kouki M Harasaki | Director | |
| Mark M Chin | Director | |
| Albert M Seymour | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 22, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ensoma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.